HUBRO BIOSCIENCE AS

Closed at April 29th, 2026, Insolvency proceedings

Utvikling og salg av biomedisinske produkter og tjenester. Formålet kan fremmes ved deltakelse i eller samarbeid med andre foretak i inn- og utland.

Forskning og utvikling av biomedisinske produkter og tjenester.

Organization

CEO: JA
Jon Amund Eriksen1954
Chairman of the board: JA
Jon Amund Eriksen1954
Operation time: 2 years; - May 21, 2024 to Apr 29, 2026
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 300,000; 1 share class
Total number of shareholders: 5; 3 companies, 2 persons
Belongs to group of

Financials

Total operating income 2024: 500,000; NOK
Annual total result 2024: -1,104,486; NOK
Total equity 2024: -1,074,486; NOK

Last update: Feb 12, 2026

Management

Management / administration

Name	Role	Shares
JA Jon Amund Eriksen 1954	Managing Director/CEO	38 % indirectly

Board

Name	Role	Shares
JA Jon Amund Eriksen 1954	Chairman	38 % indirectly
TA Tom Arne Thorsen 1967 Resigned	Board Member	52 % indirectly
RM Robert Matthew Miller 1952 Resigned	Board Member	2.5 % directly

Others

Name	Role	Shares
A AMESTO ACCOUNTHOUSE AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
TA Tom Arne Thorsen 1967	Board Member	52 % indirectly
JA Jon Amund Eriksen 1954	Managing Director/CEO, Chairman	38 % indirectly
PC Peer Christensen 1962	-	5 % indirectly
RM Robert Matthew Miller 1952	Board Member	2.5 % directly
SJ Sarah Joy Arbe Barnes 1959	-	2.5 % directly

Last update: Feb 10, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
A ALGOT INVEST AS Closed	Ordinary shares	156,000	52 %
T TIMMUNO AS Closed	Ordinary shares	114,000	38 %
V VIKINGEN AS	Ordinary shares	15,000	5 %
SJ Sarah Joy Arbe Barnes 1959	Ordinary shares	7,500	2.5 %
RM Robert Matthew Miller 1952	Ordinary shares	7,500	2.5 %

Last update: Sep 25, 2026

Group structure

ALGOT INVEST AS
Total operating income 2024: NOK 0
Operating profit 2024: NOK -156,178
Employees: 0

Financials

in NOK

Summary

Year	2024
Total operating income	500,000
Annual Total Result	-1,104,486
Total assets	447,776
Total liabilities	1,522,262
Total equity	-1,074,486

P&L

Year	2024
Total operating income	500,000
Total operating costs	1,601,983
Operating result	-1,101,983
Financial income/costs	-2,502
Profit before tax	-1,104,486
Total tax & extraordinary income/cost	0
Annual Total Result	-1,104,486

Balance overview

Year	2024
Total fixed assets	200,000
Total current assets	247,776
Total assets	447,776
Short term debt	22,262
Long term debt	1,500,000
Total liabilities	1,522,262
Contributed capital	30,000
Retained earnings	-1,104,486
Total equity	-1,074,486
Total equity and liabilities	447,776

Classification

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

HUBRO BIOSCIENCE AS933 476 561